#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	11690	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2148	535.2	1	SNP	n	C1184T	0	.	.	1184	1184	C	1426	1426	C	712	C	688	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	11690	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2148	535.2	0	HET	.	.	.	C207T,G	.	207	207	C	449	449	C	646	C,T,G	497,109,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	11690	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2148	535.2	0	HET	.	.	.	C1512T	.	1512	1512	C	1754	1754	C	571	C,T	298,261	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	11690	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2148	535.2	0	HET	.	.	.	C451T	.	451	451	C	693	693	C	672	C,T	320,328	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	22056	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3738	583.8	0	.	n	.	0	T695C	SNP	695	695	T	1090	1090	C	658	C,T	639,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	22056	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3738	583.8	0	.	n	.	0	T1971C	SNP	1971	1971	T	2366	2366	C	646	C	620	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	22056	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3738	583.8	1	SNP	n	A2045G	0	.	.	2045	2045	A	2440	2440	A	645	A	628	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	22056	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3738	583.8	1	SNP	n	C2597T	0	.	.	2597	2597	C	2992	2992	C	647	C,G,T	626,1,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	22056	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3738	583.8	0	HET	.	.	.	A1638G	.	1638	1638	A	2033	2033	A	707	A,G	562,128	.	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	1284	folP	855	855	100.0	folP.l15.c4.ctg.1	1507	84.1	1	SNP	p	R229S	1	.	.	685	687	AGC	982	984	AGC	132;130;129	A;G;C	128;127;125	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	3690	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3309	109.9	1	SNP	p	S91F	1	.	.	271	273	TTC	528	530	TTC	137;137;137	T;T;C	133;134;132	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	3690	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3309	109.9	1	SNP	p	D95G	1	.	.	283	285	GGC	540	542	GGC	132;131;132	G;G;C	127;126;126	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	3690	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3309	109.9	1	SNP	p	G95N	0	.	.	283	285	GGC	540	542	GGC	132;131;132	G;G;C	127;126;126	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	27	1150	mtrR	633	633	100.0	mtrR.l6.c30.ctg.1	1326	85.6	1	SNP	p	G45D	0	.	.	133	135	GGC	478	480	GGC	145;141;142	G;G;C	139;135;137	mtrR.WHO_V_01454:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	586	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	955	60.6	0	.	n	.	0	A197.	DEL	197	197	A	565	565	A	130	A	127	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4346	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2915	146.9	1	SNP	p	D86N	0	.	.	256	258	GAC	541	543	GAC	145;144;147	G;A;C	141;137;145	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4346	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2915	146.9	1	SNP	p	R87W	0	.	.	259	261	CGT	544	546	CGT	146;144;145	C;G;T	144;142;140	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4346	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2915	146.9	1	SNP	p	S87R	1	.	.	259	261	CGT	544	546	CGT	146;144;145	C;G;T	144;142;140	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4346	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2915	146.9	1	SNP	p	R87I	0	.	.	259	261	CGT	544	546	CGT	146;144;145	C;G;T	144;142;140	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4346	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2915	146.9	1	SNP	p	S88P	0	.	.	262	264	TCC	547	549	TCC	145;145;144	T;C;C	140;138;138	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	2912	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2584	110.9	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1510	1512	GGC	133;127;127	G;G;C	132;125;125	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	3148	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2442	126.6	1	SNP	p	A311V	0	.	.	931	933	GCC	1330	1332	GCC	158;157;157	G;C;C,T	154;155;151,1	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3148	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2442	126.6	1	SNP	p	I312M	1	.	.	934	936	ATG	1333	1335	ATG	154;154;154	A;T;G	154;153;154	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3148	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2442	126.6	1	SNP	p	V316T	1	.	.	946	948	ACC	1345	1347	ACC	157;157;158	A;C;C	151;156;154	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3148	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2442	126.6	1	SNP	p	T316P	0	.	.	946	948	ACC	1345	1347	ACC	157;157;158	A;C;C	151;156;154	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3148	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2442	126.6	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1846	1848	ACC	158;156;155	A;C;C	149;153;149	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3148	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2442	126.6	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1900	1902	GCG	140;137;140	G;C;G	135;129;134	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3148	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2442	126.6	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1900	1902	GCG	140;137;140	G;C;G	135;129;134	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3148	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2442	126.6	1	SNP	p	G542S	0	.	.	1624	1626	GGT	2023	2025	GGT	133;131;131	G;G;T	128;126;124	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3148	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2442	126.6	1	SNP	p	G545S	1	.	.	1633	1635	AGC	2032	2034	AGC	126;122;121	A;G;C	119;115;114	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3148	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2442	126.6	1	SNP	p	P551S	0	.	.	1651	1653	CCG	2050	2052	CCG	98;99;99	C,G;C,G;G	86,3;87,1;82	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	4750	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3040	153.9	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1589	1591	CCG	160;160;162	C;C;G	149;153;153	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	1910	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1730	108.2	0	.	p	.	0	M83fs	FSHIFT	247	247	A	539	539	C	133	C	128	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	208	porB1a	984	287	91.07	porB1a.l6.c17.ctg.2	377	14.4	0	.	p	.	0	H217N	NONSYN	649	651	CAT	112	114	AAT	8;8;8	A;A;T	8;8;8	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	208	porB1a	984	287	91.07	porB1a.l6.c17.ctg.2	377	14.4	0	.	p	.	0	D218N	NONSYN	652	654	GAT	115	117	AAT	8;8;8	A;A;T	8;8;8	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	208	porB1a	984	287	91.07	porB1a.l6.c17.ctg.2	377	14.4	0	.	p	.	0	V226A	NONSYN	676	678	GTA	139	141	GCA	9;9;9	G;C;A	9;9;9	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	208	porB1a	984	287	91.07	porB1a.l6.c17.ctg.2	377	14.4	0	.	p	.	0	.	MULTIPLE	700	702	ACT	162	164	GTA	8;8;8	G;T;A	8;8;8	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	208	porB1a	984	287	91.07	porB1a.l6.c17.ctg.2	377	14.4	0	.	p	.	0	N237fs	FSHIFT	709	709	A	171	171	A	8	A	8	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2338	porB1b	1038	1038	99.9	porB1b.l6.c4.ctg.1	1691	135.9	0	.	p	.	0	G210R	NONSYN	628	630	GGA	967	969	AGA	194;191;187	A,G;G;A	188,1;179;180	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2338	porB1b	1038	1038	99.9	porB1b.l6.c4.ctg.1	1691	135.9	1	SNP	p	G120K	1	.	.	358	360	AAG	697	699	AAG	191;190;190	A;A;G	182;186;179	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2338	porB1b	1038	1038	99.9	porB1b.l6.c4.ctg.1	1691	135.9	1	SNP	p	A121N	1	.	.	361	363	AAC	700	702	AAC	188;187;186	A;A,G;C	184;182,1;177	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2338	porB1b	1038	1038	99.9	porB1b.l6.c4.ctg.1	1691	135.9	1	SNP	p	N121D	0	.	.	361	363	AAC	700	702	AAC	188;187;186	A;A,G;C	184;182,1;177	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	8320	rpoB	4179	4179	99.98	rpoB.l15.c17.ctg.1	4899	167.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	994	rpsJ	312	312	100.0	rpsJ.l6.c30.ctg.1	1104	88.8	1	SNP	p	V57M	1	.	.	169	171	ATG	601	603	ATG	197;198;196	A;T;G	191;192;191	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
